Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 7, 2001, Pages 2154-2156

  Prystowsky, J ^a   Siddiqui, F ^a   Chosay, J ^a   Shinabarger, D L ^a   Millichap, J ^a   Peterson, L R ^a   Noskin, G A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; GUANINE; LINEZOLID; RIBOSOME RNA; URACIL; VANCOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; DNA SEQUENCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; OXAZOLIDINONES; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; VANCOMYCIN RESISTANCE;

EID: 0034962929     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.7.2154-2156.2001     Document Type: Article

References (16)

1. Application of tRNA intergenic spacer PCR for identification of enterococcus species
2. National Nosocomial Infection Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999
3. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds
4. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound
5. In vitro activities of oxazolidinone compounds U-100592 and U-100766 against Staphylococcus aureus and Staphylococcus epidermidis
6. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin
7. Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using step-wise in vitro exposure
8. Vancomycin-resistant enterococci: Clinical, microbiologic, and epidemiologic features
9. In vitro activity of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci
10. Recovery of vancomycin resistant enterococci on fingertips and environmental surfaces
11. Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid
12. Mechanism of action of the oxazolidinone antibacterial agents
13. Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions
14. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria
15. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents